BCAT1
Branched-chain-amino-acid aminotransferase, cytosolic
Also known as: BCAT1_HUMAN, BCATc, BCT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54687
- Gene
- BCAT1
- Ensembl
- ENSG00000060982
- Chromosome
- 12
- Canonical length
- 386 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
386 residues, UniProt reviewed canonical sequence.
>P54687|BCAT1
1 MKDCSNGCSA ECTGEGGSKE VVGTFKAKDL IVTPATILKE KPDPNNLVFG TVFTDHMLTV
61 EWSSEFGWEK PHIKPLQNLS LHPGSSALHY AVELFEGLKA FRGVDNKIRL FQPNLNMDRM
121 YRSAVRATLP VFDKEELLEC IQQLVKLDQE WVPYSTSASL YIRPTFIGTE PSLGVKKPTK
181 ALLFVLLSPV GPYFSSGTFN PVSLWANPKY VRAWKGGTGD CKMGGNYGSS LFAQCEAVDN
241 GCQQVLWLYG EDHQITEVGT MNLFLYWINE DGEEELATPP LDGIILPGVT RRCILDLAHQ
301 WGEFKVSERY LTMDDLTTAL EGNRVREMFG SGTACVVCPV SDILYKGETI HIPTMENGPK
361 LASRILSKLT DIQYGREESD WTIVLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 55 nTPM
- placenta: 14 nTPM
- retina: 13 nTPM
- lung: 9.1 nTPM
- midbrain: 8.5 nTPM
- ovary: 8.2 nTPM
Single-cell type
- pancreatic acinar cells: 545 nCPM
- late spermatids: 541 nCPM
- retinal bipolar cells: 458 nCPM
- cdc: 346 nCPM
- retinal pigment epithelial cells: 328 nCPM
- macrophages: 268 nCPM
Immune cell
- non-classical monocyte: 17 nTPM
- myeloid DC: 5.8 nTPM
- intermediate monocyte: 3.6 nTPM
- plasmacytoid DC: 3.5 nTPM
- classical monocyte: 2.3 nTPM
- memory B-cell: 1.1 nTPM
Brain region
- pons: 62 nTPM
- hypothalamus: 57 nTPM
- midbrain: 57 nTPM
- medulla oblongata: 48 nTPM
- thalamus: 45 nTPM
- cerebral cortex: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.22
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- branched-chain amino acid biosynthetic process
- branched-chain amino acid catabolic process
- G1/S transition of mitotic cell cycle
- L-leucine biosynthetic process
- L-valine biosynthetic process
- lipid metabolic process
Molecular functions
- branched-chain-amino-acid transaminase activity
- L-isoleucine-2-oxoglutarate transaminase activity
- L-leucine-2-oxoglutarate transaminase activity
- L-valine-2-oxoglutarate transaminase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aminotransferase class IV
- Branched-chain amino acid aminotransferase II
- Aminotransferase, class IV, conserved site
- Branched-chain aminotransferase
- Aminotransferase-like, PLP-dependent enzymes
- Branched-chain-amino-acid aminotransferase-like, N-terminal
- Branched-chain-amino-acid aminotransferase-like, C-terminal
- Amino-transferase class IV
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCAT1 as an antibody target. Whether an autoantibody or antibody against BCAT1 could matter depends on whether native BCAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...